NCT05267821: An ongoing trial by Nationwide Children's Hospital
This trial is ongoing. It must report results 3 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05267821 |
|---|---|
| Title | Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (TRIPS) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 14, 2022 |
| Completion date | May 15, 2027 |
| Required reporting date | May 14, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |